ClinConnect ClinConnect Logo
Search / Trial NCT07079943

TRAJ : Transition in Rheumatology, From Adolescence to Adulthood

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Jul 22, 2025

Trial Information

Current as of November 11, 2025

Not yet recruiting

Keywords

Transitional Care Lost To Follow Up Patient Reported Experience Quality Of Life Patient Satisfaction

ClinConnect Summary

This clinical trial is looking at how well a special support program called CAPAdJA helps young people with chronic rheumatic diseases continue their medical care as they move from child to adult healthcare services. The study will compare how many patients stay in regular follow-up care six months after their transition appointment, between those who used the CAPAdJA program and those who did not. This is important because keeping up with care during this change can be challenging, and the program aims to make it easier.

To take part, patients must have had a transition consultation from pediatric to adult rheumatology care at Bordeaux University Hospital between 2017 and 2024 and be over 18 years old when filling out a questionnaire. The study is open to all genders, but participants need to speak French and agree to join. If you join, you will complete a questionnaire about your healthcare experience after the transition. This study is not yet recruiting, but it hopes to improve how young adults with rheumatic diseases manage their care during this important time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who benefited from a pediatric-to-adult rheumatology transition consultation at Bordeaux University Hospital between 2017 and 2024
  • Patients over 18 years old at the time of completing the self-administered questionnaire.
  • Exclusion Criteria:
  • Patients who do not speak French
  • Patients who have refused to participating

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Bordeaux, France

Patients applied

0 patients applied

Trial Officials

Olivier RICHER, MD

Principal Investigator

University Hospital, Bordeaux

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported